The Evolution of Myasthenia Gravis-Activities of Daily Living (MG-ADL) Scale Utilization to Measure Myasthenia Gravis Symptoms and Treatment Response

被引：0
|
作者：
Muppidi, Srikanth
Silvestri, Nicholas [1 ]
Tan, Robin [2 ]
Riggs, Kimberly [2 ]
Leighton, Trevor [3 ]
机构：
[1] UBMD Neurol, Williamsville, NY USA
[2] Xcenda, Washington, DC USA
[3] Argenx, Amsterdam, Netherlands
来源：
NEUROLOGY | 2021年 / 96卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1817
引用
收藏
页数：3
相关论文
共 42 条
  • [1] Myasthenia Gravis Activities of Daily Living (MG-ADL) Response to Eculizumab Treatment in Patients from the Generalized Myasthenia Gravis Registry
    Greene, Ericka
    Cutter, Gary
    Muppidi, Srikanth
    Juel, Vern
    Rodrigues, Ema
    Korideck, Houari
    Howard, James, Jr.
    NEUROLOGY, 2023, 100 (17)
  • [2] Comparison of the Quantitative Myasthenia Gravis (QMG) and Myasthenia Gravis Activities of Daily Living (MG-ADL) scores in the MGTX Randomized Trial
    McPherson, Tarrant
    Aban, Immaculada
    Duda, Petra
    Farzaneh-Far, Ramin
    Wolfe, Gil
    Kaminski, Henry
    Cutter, Gary
    NEUROLOGY, 2019, 92 (15)
  • [3] Utilization of MG-ADL in myasthenia gravis clinical research and care
    Muppidi, Srikanth
    Silvestri, Nicholas J.
    Tan, Robin
    Riggs, Kimberly
    Leighton, Trevor
    Phillips, Glenn A.
    MUSCLE & NERVE, 2022, 65 (06) : 630 - 639
  • [4] Reliability and Validity of Turkish Myasthenia Gravis-Activities of Daily Living Scale
    Karanfil, Ecem
    Salci, Yeliz
    Fil-Balkan, Ayla
    Bekircan-Kurt, Can Ebru
    Ozdamar, Sevim Erdem
    Armutlu, Kadriye
    OTJR-OCCUPATION PARTICIPATION AND HEALTH, 2021, 41 (02) : 101 - 107
  • [5] CORRELATION BETWEEN MYASTHENIA GRAVIS-ACTIVITIES OF DAILY LIVING (MG-ADL) AND QUANTITATIVE MYASTHENIA GRAVIS (QMG) ASSESSMENTS OF ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY-POSITIVE REFRACTORY GENERALIZED MYASTHENIA GRAVIS IN THE PHASE 3 REGAIN STUDY
    Vissing, John
    O'Brien, Fanny
    Wang, Jing Jing
    Howard, James F., Jr.
    MUSCLE & NERVE, 2018, 58 (02) : E21 - E22
  • [6] Sensitivity of MG-ADL for generalized weakness in myasthenia gravis
    de Meel, R. H. P.
    Raadsheer, W. F.
    van Zwet, E. W.
    Verschuuren, J. J. G. M.
    Tannemaat, M. R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 (06) : 947 - 950
  • [7] RETROSPECTIVE LONGITUDINAL ASSESSMENT OF MG-ADL SCORE WITH TREATMENT OF MYASTHENIA GRAVIS
    Varon, Matthew
    Pasnoor, Mamatha
    Winden, Tamara
    Hunt, Suzanne
    Jawdat, Omar
    Farmakidis, Constantine
    Jabari, Duaa
    Glenn, Melanie
    Statland, Jeffrey
    Barohn, Richard
    Dimachkie, Mazen
    MUSCLE & NERVE, 2019, 60 : S131 - S131
  • [8] QMG AND MG-ADL CORRELATIONS: STUDY OF ECULIZUMAB TREATMENT OF MYASTHENIA GRAVIS
    Howard, James F., Jr.
    Freimer, Miriam
    O'Brien, Fanny
    Wang, Jing Jing
    Collins, Stephen R.
    Kissel, John T.
    MUSCLE & NERVE, 2017, 56 (02) : 328 - 330
  • [9] Retrospective longitudinal assessment of MG-ADL score with treatment of myasthenia gravis
    Varon, Matthew
    Pasnoor, Mamatha
    Winden, Tamara
    Hunt, Suzanne
    Jawdat, Omar
    Farmakidis, Constantine
    Jabari, Duaa
    Glenn, Melanie
    Statland, Jeffrey
    Barohn, Richard
    Dimachkie, Mazen
    NEUROLOGY, 2019, 92 (15)
  • [10] Concordance between patient- and physician-reported Myasthenia Gravis Activities of Daily Living (MG-ADL) scores
    Dewilde, Sarah
    Janssen, M. F.
    Tollenaar, Nafthali H.
    Vanoli, Fiammetta
    Frangiamore, Rita
    Phillips, Glenn
    Paci, Sandra
    Mantegazza, Renato
    Meisel, Andreas
    Stascheit, Frauke
    MUSCLE & NERVE, 2023, 68 (01) : 65 - 72
12345